Details for New Drug Application (NDA): 011641
✉ Email this page to a colleague
NDA 011641 describes DIABINESE, which is a drug marketed by Pfizer and is included in one NDA. Additional details are available on the DIABINESE profile page.
The generic ingredient in DIABINESE is chlorpropamide. There are eleven drug master file entries for this compound. Additional details are available on the chlorpropamide profile page.
The generic ingredient in DIABINESE is chlorpropamide. There are eleven drug master file entries for this compound. Additional details are available on the chlorpropamide profile page.
Summary for 011641
| Tradename: | DIABINESE |
| Applicant: | Pfizer |
| Ingredient: | chlorpropamide |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 011641
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Profile for product number 006
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 250MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
